Related Experiment Video
Updated: May 23, 2026

11:35
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Alternative methods for H1 simulations in genome-wide association studies
V Perduca1, C Sinoquet, R Mourad
1MAP5 - UMR CNRS 8145, Université Paris Descartes, Paris, France. vittorio.perduca @ parisdescartes.fr
Human Heredity
|April 5, 2012
Summary
We developed a faster method for simulating phenotypes in genome-wide association studies. This approach enhances statistical power assessment without complex genotype modeling, offering a flexible alternative to existing tools.
Area of Science:
- Genetics
- Statistical genetics
- Computational biology
Background:
- Statistical power is crucial for genome-wide association (GWA) studies.
- Empirical power estimation involves simulating phenotypes under a disease model (H1).
- Current gold standard methods (e.g., Hapgen) simulate genotypes based on phenotypes.
Purpose of the Study:
- Introduce a novel, faster approach for simulating phenotypes under H1.
- Avoids the need for generating new genotypes for each simulation.
- Provides a flexible and efficient alternative for power assessment in GWA studies.
Main Methods:
- Developed three algorithms: rejection sampling, Markov chain Monte Carlo (MCMC), and backward sampling.
- Validated algorithms on simulated and realistic datasets, comparing with Hapgen.
- Applied the method to a 1000 Genomes Project dataset (629 individuals, 8,048 SNPs on chromosome X) with an additive model and epistasis.
Main Results:
- All three algorithms yielded consistent results, with backward sampling being significantly faster.
- The proposed method produced results comparable to Hapgen.
- Epistatic effects were shown to be significant even with simple marker statistics.
- GWA study performance is highly dependent on disease prevalence, with higher prevalence improving power.
Conclusions:
- The developed approach is a viable and faster alternative to Hapgen-type methods.
- Advantages include no need for complex genotype models (haplotypes, recombination rates).
- Offers unconstrained disease model selection (SNPs, gene-environment interactions, hybrid models).
- Algorithms are available in the R package 'waffect'.

